ADXN Company Profile and Key Details

Q: Who are the executives of ADXN?

Dr. Werner Henrichi Ph.D.ConsultantMr. Timothy Mark DyerCo-Founder, Chief Executive Officer & DirectorDr. Roger G. Mills M.D.Chief Medical Officer & DirectorMr. Lénaic TeyssédouHead of Fin.Dr. Jean-Philippe Rocher Ph.D.Head of Discovery - ChemistryDr. Robert LutjensHead of Discovery - BiologyDr. Mikhail Kalinichev Ph.D.Head of Translational Science

NASDAQ : ADXN

Addex Therapeutics

$4.94

0.37+8.10%

At Close 4:00 PM

75.62

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Addex Therapeutics Ltd (ADXN) stock surged +8.10%, trading at $4.94 on NASDAQ, up from the previous close of $4.57. The stock opened at $5.87, fluctuating between $4.60 and $6.03 in the recent session.

Stock Snapshot

4.57

Prev. Close

6.09M

Market Cap

4.6

Day Low

-0.78

P/E Ratio

-6.29751

EPS (TTM)

-0.08

Cash Flow per Share

5.87

Open

1.23M

Number of Shares

6.033

Day High

99.97%

Free Float in %

0.01

Book Value

7.27M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Aug 21, 2026	5.87	6.05	4.60	4.94	7.25M
Aug 20, 2026	5.87	6.21	3.78	4.57	245.6K
Aug 19, 2026	5.74	5.98	5.74	5.98	110.83
Aug 18, 2026	5.70	5.99	5.57	5.57	0.83
Aug 17, 2026	5.70	5.70	5.70	5.70	406
Aug 14, 2026	5.55	5.55	5.55	5.55	104
Aug 13, 2026	5.86	5.86	5.55	5.55	446.83
Aug 12, 2026	5.98	6.00	5.38	5.95	52.42
Aug 11, 2026	5.93	5.93	5.55	5.86	1
Aug 10, 2026	5.95	5.95	5.95	5.95	2.11K
Aug 07, 2026	5.42	5.85	5.40	5.40	57.83
Aug 06, 2026	5.72	5.80	5.67	5.80	2.11K
Aug 05, 2026	5.42	5.75	5.22	5.22	2.83
Aug 04, 2026	5.75	6.16	5.69	5.69	2.81K
Aug 03, 2026	5.53	6.08	5.41	6.07	904.83
Jul 31, 2026	5.90	6.00	5.04	5.20	4.36K
Jul 30, 2026	5.80	5.80	5.60	5.60	3.07K
Jul 29, 2026	5.60	5.60	5.60	5.60	1.82K
Jul 28, 2026	5.95	6.08	5.95	6.08	18.83
Jul 27, 2026	6.05	6.16	5.82	6.16	0

Contact Details

Geneva, GE 1202

Switzerland

https://www.addextherapeutics.com 412 288 41555

About Company

Addex Therapeutics Ltd, a biopharmaceutical firm in a developmental phase, operates out of Switzerland, focusing on the discovery, advancement, and commercialization of small-molecule drugs targeting central nervous system (CNS) disorders. Their core strategy involves identifying oral small-molecule allosteric modulators for G-protein coupled receptors. The company's key programs include Dipraglurant, an investigational treatment for Parkinson's disease levodopa-induced dyskinesia and dystonia; ADX71149, which is being developed for epilepsy and other unspecified CNS conditions; and GABAB PAM, a compound aimed at treating addiction. Addex Therapeutics has established licensing and collaboration agreements with significant partners, including Janssen Pharmaceuticals Inc., Indivior PLC, and The Charcot–Marie–Tooth Association. Founded in 2002 and based in Geneva, Switzerland, the company was initially known as Addex Pharmaceuticals Ltd before officially changing its name to Addex Therapeutics Ltd in March 2012.

Stock Peers

ARGX

1.66+0.16%

argenx SE$1,039.78 REGN

7.4+0.90%

Regeneron Pharmaceuticals, Inc.$834.04 VRTX

7.79+1.44%

Vertex Pharmaceuticals Incorporated$548.05 MDGL

-2.35-0.45%

Madrigal Pharmaceuticals, Inc.$516.74 UTHR

-7.88-1.51%

United Therapeutics Corporation$513.12 PRAX

11.36+3.12%

Praxis Precision Medicines, Inc.$375.94 ONC

5.31+1.44%

BeOne Medicines AG$374.47 KRYS

9.56+2.84%

Krystal Biotech, Inc.$346.58 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

-1.1-0.38%

Ligand Pharmaceuticals Incorporated$286.29

Frequently Asked Questions

What is the current Addex Therapeutics Ltd (ADXN) stock price?

Addex Therapeutics Ltd (NASDAQ: ADXN) stock price is $4.94 in the last trading session. During the trading session, ADXN stock reached the peak price of $6.03 while $4.60 was the lowest point it dropped to. The percentage change in ADXN stock occurred in the recent session was 8.1% while the dollar amount for the price change in ADXN stock was $0.37.

ADXN's industry and sector of operation?

The NASDAQ listed ADXN is part of Biotechnology industry that operates in the broader Healthcare sector. Addex Therapeutics Ltd designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ADXN?

Dr. Werner Henrichi Ph.D.
Consultant
Mr. Timothy Mark Dyer
Co-Founder, Chief Executive Officer & Director
Dr. Roger G. Mills M.D.
Chief Medical Officer & Director
Mr. Lénaic Teyssédou
Head of Fin.
Dr. Jean-Philippe Rocher Ph.D.
Head of Discovery - Chemistry
Dr. Robert Lutjens
Head of Discovery - Biology
Dr. Mikhail Kalinichev Ph.D.
Head of Translational Science

How ADXN did perform over past 52-week?

ADXN's closing price is 30.69% higher than its 52-week low of $3.78 where as its distance from 52-week high of $12.05 is -59%.

How many employees does ADXN have?

Number of ADXN employees currently stands at 3.

Link for ADXN official website?

Official Website of ADXN is: https://www.addextherapeutics.com

How do I contact ADXN?

ADXN could be contacted at phone 412 288 41555 and can also be accessed through its website. ADXN operates from Chemin des Mines, 9, Geneva, GE 1202, Switzerland.

How many shares of ADXN are traded daily?

ADXN stock volume for the day was 7.27M shares. The average number of ADXN shares traded daily for last 3 months was 123.42K.

What is the market cap of ADXN currently?

The market value of ADXN currently stands at $6.09M with its latest stock price at $4.94 and 1.23M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	3
Beta	2
Sales or Revenue	$1.61M
5Y Sales Change%	-0.916%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	3
Beta	2
Sales or Revenue	$1.61M
5Y Sales Change%	-0.916%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

ADXN Company Profile and Key Details

Addex Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Dividend & Fair Value

Technical Performance

Valuation Metrics

Key Takeaways

Price Forecast & Outlook